Andere Kunden interessierten sich auch für
![Prognostic Impact of Apoptosis Markers (Fas & FasL) in Bladder Cancer]( "Prognostic Impact of Apoptosis Markers (Fas & FasL) in Bladder Cancer")
Prognostic Impact of Apoptosis Markers (Fas & FasL) in Bladder Cancer26,99 €![Prognostic markers and Cancer]( "Prognostic markers and Cancer")
Prognostic markers and Cancer36,99 €![Emergency Management of the Pre-Hospital Phase in Covid-19 Patient]( "Emergency Management of the Pre-Hospital Phase in Covid-19 Patient")
Emergency Management of the Pre-Hospital Phase in Covid-19 Patient26,99 €![Diagnostic Prognostic Importance of Tumor Marker and Enzymes]( "Diagnostic Prognostic Importance of Tumor Marker and Enzymes")
Diagnostic Prognostic Importance of Tumor Marker and Enzymes26,99 €![Nexus of Metabolic Syndrome and Periodontal disease]( "Nexus of Metabolic Syndrome and Periodontal disease")
Nexus of Metabolic Syndrome and Periodontal disease36,99 €![Salivary Melatonin And Severity Of Periodontal Disease]( "Salivary Melatonin And Severity Of Periodontal Disease")
Salivary Melatonin And Severity Of Periodontal Disease32,99 €![Tumor markers in gynecological cancers]( "Tumor markers in gynecological cancers")
Tumor markers in gynecological cancers24,99 €
Periodontal diseases are characterized by a complex set of biologic interactions between a diverse and dynamic microbial ecosystem and the host s multifaceted immune and inflammatory machinery. Such interactions between microbial pathogens and various host response systems play a critical role in the development and progression of periodontal disease via the release of inflammatory and immune mediators. Advances in periodontal disease diagnostic are moving toward methods whereby periodontal risk can be identified and quantified by detecting such inflammatory mediators in its sequential pathophysiology. Evidence suggests that acute-phase proteins acts as a non-redundant component of the humoral arm of innate immunity, as well as a tuner of inflammation. In Periodontal diagnostics, it has been a great challenge to determine biomarkers for screening and predicting the early onset of disease (prognostic tests) or evaluating the disease activity and the efficacy of therapy. Hence the need of advanced markers to accurately identify the disease with high sensitivity and specificity were sought. Acute phase proteins in general come close to fulfill these criteria.